MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity
Dong Cheng, Bradley A. Zinker, Yi Luo, Petia Shipkova, Claudia H. De Oliveira, Gopal Krishna, Elizabeth A. Brown, Stephanie Boehm, Giridhar Tirucherai, Huidong Gu, Zhengping Ma, Ching-Hsuen Chu, Joelle M. Onorato, Lisa M. Kopcho, Ron Ammar, Julia Smith, Pratik Devasthale, R. Michael Lawrence, Steven A. Stryker, Elizabeth A. Dierks, Anthony V. Azzara, Leon Carayannopoulos, Edgar D. Charles, Kimberley A. Lentz, David A. Gordon
Topics & Concepts
SteatosisEndocrinologyInflammationInternal medicineWeight lossNonalcoholic fatty liver diseasePharmacologyFibrosisMonoacylglycerol lipaseMedicineBiologyFatty liverObesityDiseaseReceptorEndocannabinoid systemLiver Disease Diagnosis and TreatmentLipid metabolism and biosynthesisPancreatic function and diabetes